July 27th, 2011
Mixed Results for New Implantable Device to Treat Resistant Hypertension
Larry Husten, PHD
A phase III trial has yielded mixed results for an experimental implantable device that uses baroreflex activation therapy (BAT) to treat resistant hypertension. The article on the manufacturer-funded Rheos Pivotal Trial, by John Bisognano and colleagues, has been published online in the Journal of the American College of Cardiology. The Rheos device was implanted in 265 […]
NEJM Journal Watch — Recent Cardiology Articles- Anticoagulation in Patients with Cancer-Associated Pulmonary Embolism: How Long is Long Enough?
- Spironolactone Use After Percutaneous Intervention for Acute Myocardial Infarction
- CRISPR/Cas9 Gene Editing for Transthyretin Cardiomyopathy
- Does Colchicine Reduce Cardiac Events After Myocardial Infarction?
- First-Line Therapy for Ventricular Tachycardia After MI: What's the Best Approach?